168 related articles for article (PubMed ID: 21366266)
1. Discovery of a potent and efficacious peptide derivative for δ/μ opioid agonist/neurokinin 1 antagonist activity with a 2',6'-dimethyl-L-tyrosine: in vitro, in vivo, and NMR-based structural studies.
Yamamoto T; Nair P; Largent-Milnes TM; Jacobsen NE; Davis P; Ma SW; Yamamura HI; Vanderah TW; Porreca F; Lai J; Hruby VJ
J Med Chem; 2011 Apr; 54(7):2029-38. PubMed ID: 21366266
[TBL] [Abstract][Full Text] [Related]
2. Discovery of Novel Multifunctional Ligands with μ/δ Opioid Agonist/Neurokinin-1 (NK1) Antagonist Activities for the Treatment of Pain.
Giri AK; Apostol CR; Wang Y; Forte BL; Largent-Milnes TM; Davis P; Rankin D; Molnar G; Olson KM; Porreca F; Vanderah TW; Hruby VJ
J Med Chem; 2015 Nov; 58(21):8573-83. PubMed ID: 26465170
[TBL] [Abstract][Full Text] [Related]
3. Improving metabolic stability by glycosylation: bifunctional peptide derivatives that are opioid receptor agonists and neurokinin 1 receptor antagonists.
Yamamoto T; Nair P; Jacobsen NE; Vagner J; Kulkarni V; Davis P; Ma SW; Navratilova E; Yamamura HI; Vanderah TW; Porreca F; Lai J; Hruby VJ
J Med Chem; 2009 Aug; 52(16):5164-75. PubMed ID: 20560643
[TBL] [Abstract][Full Text] [Related]
4. The importance of micelle-bound states for the bioactivities of bifunctional peptide derivatives for delta/mu opioid receptor agonists and neurokinin 1 receptor antagonists.
Yamamoto T; Nair P; Jacobsen NE; Davis P; Ma SW; Navratilova E; Moye S; Lai J; Yamamura HI; Vanderah TW; Porreca F; Hruby VJ
J Med Chem; 2008 Oct; 51(20):6334-47. PubMed ID: 18821747
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and biological evaluation of novel bifunctional C-terminal-modified peptides for delta/mu opioid receptor agonists and neurokinin-1 receptor antagonists.
Yamamoto T; Nair P; Davis P; Ma SW; Navratilova E; Moye S; Tumati S; Lai J; Vanderah TW; Yamamura HI; Porreca F; Hruby VJ
J Med Chem; 2007 Jun; 50(12):2779-86. PubMed ID: 17516639
[TBL] [Abstract][Full Text] [Related]
6. A structure-activity relationship study and combinatorial synthetic approach of C-terminal modified bifunctional peptides that are delta/mu opioid receptor agonists and neurokinin 1 receptor antagonists.
Yamamoto T; Nair P; Vagner J; Largent-Milnes T; Davis P; Ma SW; Navratilova E; Moye S; Tumati S; Lai J; Yamamura HI; Vanderah TW; Porreca F; Hruby VJ
J Med Chem; 2008 Mar; 51(5):1369-76. PubMed ID: 18266313
[TBL] [Abstract][Full Text] [Related]
7. Discovery of tripeptide-derived multifunctional ligands possessing delta/mu opioid receptor agonist and neurokinin 1 receptor antagonist activities.
Nair P; Yamamoto T; Cowell S; Kulkarni V; Moye S; Navratilova E; Davis P; Ma SW; Vanderah TW; Lai J; Porreca F; Hruby VJ
Bioorg Med Chem Lett; 2015 Sep; 25(17):3716-20. PubMed ID: 26212775
[TBL] [Abstract][Full Text] [Related]
8. Truncation of the peptide sequence in bifunctional ligands with mu and delta opioid receptor agonist and neurokinin 1 receptor antagonist activities.
Nair P; Yamamoto T; Largent-Milnes TM; Cowell S; Kulkarni V; Moye S; Navratilova E; Davis P; Ma SW; Vanderah TW; Lai J; Porreca F; Hruby VJ
Bioorg Med Chem Lett; 2013 Sep; 23(17):4975-8. PubMed ID: 23899615
[TBL] [Abstract][Full Text] [Related]
9. Novel ligands lacking a positive charge for the delta- and mu-opioid receptors.
Schiller PW; Berezowska I; Nguyen TM; Schmidt R; Lemieux C; Chung NN; Falcone-Hindley ML; Yao W; Liu J; Iwama S; Smith AB; Hirschmann R
J Med Chem; 2000 Feb; 43(4):551-9. PubMed ID: 10691681
[TBL] [Abstract][Full Text] [Related]
10. Biological and conformational evaluation of bifunctional compounds for opioid receptor agonists and neurokinin 1 receptor antagonists possessing two penicillamines.
Yamamoto T; Nair P; Jacobsen NE; Kulkarni V; Davis P; Ma SW; Navratilova E; Yamamura HI; Vanderah TW; Porreca F; Lai J; Hruby VJ
J Med Chem; 2010 Aug; 53(15):5491-501. PubMed ID: 20617791
[TBL] [Abstract][Full Text] [Related]
11. Bioactivity of new mu and delta opioid peptides.
Capasso A
Med Chem; 2007 Sep; 3(5):480-7. PubMed ID: 17897075
[TBL] [Abstract][Full Text] [Related]
12. Delta opioidmimetic antagonists: prototypes for designing a new generation of ultraselective opioid peptides.
Salvadori S; Attila M; Balboni G; Bianchi C; Bryant SD; Crescenzi O; Guerrini R; Picone D; Tancredi T; Temussi PA
Mol Med; 1995 Sep; 1(6):678-89. PubMed ID: 8529134
[TBL] [Abstract][Full Text] [Related]
13. The opioid mu agonist/delta antagonist DIPP-NH(2)[Psi] produces a potent analgesic effect, no physical dependence, and less tolerance than morphine in rats.
Schiller PW; Fundytus ME; Merovitz L; Weltrowska G; Nguyen TM; Lemieux C; Chung NN; Coderre TJ
J Med Chem; 1999 Sep; 42(18):3520-6. PubMed ID: 10479285
[TBL] [Abstract][Full Text] [Related]
14. Cyclic beta-casomorphin analogues with mixed mu agonist/delta antagonist properties: synthesis, pharmacological characterization, and conformational aspects.
Schmidt R; Vogel D; Mrestani-Klaus C; Brandt W; Neubert K; Chung NN; Lemieux C; Schiller PW
J Med Chem; 1994 Apr; 37(8):1136-44. PubMed ID: 8164255
[TBL] [Abstract][Full Text] [Related]
15. Opiate aromatic pharmacophore structure-activity relationships in CTAP analogues determined by topographical bias, two-dimensional NMR, and biological activity assays.
Bonner GG; Davis P; Stropova D; Edsall S; Yamamura HI; Porreca F; Hruby VJ
J Med Chem; 2000 Feb; 43(4):569-80. PubMed ID: 10691683
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the Dmt-Tic pharmacophore: conversion of a potent delta-opioid receptor antagonist into a potent delta agonist and ligands with mixed properties.
Balboni G; Guerrini R; Salvadori S; Bianchi C; Rizzi D; Bryant SD; Lazarus LH
J Med Chem; 2002 Jan; 45(3):713-20. PubMed ID: 11806723
[TBL] [Abstract][Full Text] [Related]
17. Design of novel neurokinin 1 receptor antagonists based on conformationally constrained aromatic amino acids and discovery of a potent chimeric opioid agonist-neurokinin 1 receptor antagonist.
Ballet S; Feytens D; Buysse K; Chung NN; Lemieux C; Tumati S; Keresztes A; Van Duppen J; Lai J; Varga E; Porreca F; Schiller PW; Vanden Broeck J; Tourwé D
J Med Chem; 2011 Apr; 54(7):2467-76. PubMed ID: 21413804
[TBL] [Abstract][Full Text] [Related]
18. Studies on the structure-activity relationship of 2',6'-dimethyl-l-tyrosine (Dmt) derivatives: bioactivity profile of H-Dmt-NH-CH(3).
Fujita Y; Tsuda Y; Motoyama T; Li T; Miyazaki A; Yokoi T; Sasaki Y; Ambo A; Niizuma H; Jinsmaa Y; Bryant SD; Lazarus LH; Okada Y
Bioorg Med Chem Lett; 2005 Feb; 15(3):599-602. PubMed ID: 15664820
[TBL] [Abstract][Full Text] [Related]
19. Development of potent bifunctional endomorphin-2 analogues with mixed mu-/delta-opioid agonist and delta-opioid antagonist properties.
Fujita Y; Tsuda Y; Li T; Motoyama T; Takahashi M; Shimizu Y; Yokoi T; Sasaki Y; Ambo A; Kita A; Jinsmaa Y; Bryant SD; Lazarus LH; Okada Y
J Med Chem; 2004 Jul; 47(14):3591-9. PubMed ID: 15214786
[TBL] [Abstract][Full Text] [Related]
20. Bifunctional μ/δ opioid peptides: variation of the type and length of the linker connecting the two components.
Ding J; Lemieux C; Chung NN; Schiller PW
Chem Biol Drug Des; 2012 Feb; 79(2):186-93. PubMed ID: 22070627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
